Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours
Histopathology · 2023
DOI: 10.1111/his.14912 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2023. Verfasst von Elena V Preobrazhenskaya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia. Hauptthemen laut MEDLINE: Neoplasms, Granuloma, Plasma Cell. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Introduction
Inflammatory myofibroblastic tumours (IMTs), being an exceptionally rare category of paediatric neoplasms, often contain druggable gene rearrangements involving tyrosine kinases. Methods and results This study presents a large consecutive series of IMTs which were analysed for the presence of translocations by the PCR test for 5′/3′‐end ALK , ROS1 , RET , NTRK1 , NTRK2 and NTRK3 unbalanced expression, variant‐specific PCR for 47 common gene fusions and NGS TruSight RNA fusion panel. Kinase gene rearrangements were detected in 71 of 82 (87%) IMTs ( ALK : n = 47; ROS1 : n = 20; NTRK3 : n = 3; PDGFRb : n = 1). The test for unbalanced expression had 100% reliability in identifying tumours with ALK fusions, but failed to reveal ROS1 rearrangements in eight of 20 (40%) ROS1 ‐driven IMTs; however, ROS1 alterations were detectable by variant‐specific PCR in 19 of 20 (95%) cases. ALK rearrangements were particularly common in patients below 1 year of age (10 of 11 (91%) versus 37 of 71 (52%), P = 0.039). ROS1 fusions occurred more often in lung IMTs than in tumours of other organs (14 of 35 (40%) versus six of 47 (13%), P = 0.007). Among 11 IMTs with no kinase gene rearrangement identified, one tumour demonstrated ALK activation via gene amplification and overexpression, and another neoplasm carried COL1A1 :: USP6 translocation.
Conclusions
PCR‐based pipeline provides a highly efficient and non‐expensive alternative for molecular testing of IMTs. IMTs with no detectable rearrangements need further studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint-Petersburg, Russia.
- Department of Medical Genetics, St.-Petersburg Pediatric Medical University, Saint-Petersburg, Russia.
- Institute of Pediatric Oncology, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.
ORCID-Profile: Elena V Preobrazhenskaya
Förderung
- Russian Science Foundation
Zitieren
APA
Preobrazhenskaya, E. V., Suleymanova, A. M., Bizin, I. V., Zagrebin, F. A., Romanko, A. A., Saitova, E. S., Mulkidzhan, R. S., & Imyanitov, E. N. (2023). Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours. Histopathology. https://doi.org/10.1111/his.14912
Vancouver
Preobrazhenskaya EV, Suleymanova AM, Bizin IV, Zagrebin FA, Romanko AA, Saitova ES, et al. Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours. Histopathology. 2023. doi:10.1111/his.14912
BibTeX
@article{Preobrazhenskaya2023,
author = {Preobrazhenskaya, Elena V and Suleymanova, Amina M and Bizin, Ilya V and Zagrebin, Fyodor A and Romanko, Alexandr A and Saitova, Evgeniya S and Mulkidzhan, Rimma S and Imyanitov, Evgeny N},
title = {Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours},
journal = {Histopathology},
year = {2023},
doi = {10.1111/his.14912}
}
EUVIMED